Evidence map›Paper›PMID 38992289›Full record

ArticleGene therapy2024

Correction: Dual-targeted NIS polyplexes-a theranostic strategy toward tumors with heterogeneous receptor expression.

Sarah Urnauer, Kathrin A Schmohl, Mariella Tutter, Christina Schug, Nathalie Schwenk, Stephan Morys, Sibylle Ziegler, Peter Bartenstein, Dirk-André Clevert, Ernst Wagner and 1 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Gene therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Sarah UrnauerDepartment of Internal Medicine IV, University Hospital of Munich, LMU Munich, Munich, Germany.
Kathrin A SchmohlDepartment of Internal Medicine IV, University Hospital of Munich, LMU Munich, Munich, Germany.
Mariella TutterDepartment of Internal Medicine IV, University Hospital of Munich, LMU Munich, Munich, Germany.
Christina SchugDepartment of Internal Medicine IV, University Hospital of Munich, LMU Munich, Munich, Germany.
Nathalie SchwenkDepartment of Internal Medicine IV, University Hospital of Munich, LMU Munich, Munich, Germany.
Stephan MorysDepartment of Pharmacy, Center of Drug Research, Pharmaceutical Biotechnology, LMU Munich, Munich, Germany.
Sibylle ZieglerDepartment of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.
Peter BartensteinDepartment of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.
Dirk-André ClevertDepartment of Clinical Radiology, University Hospital of Munich, LMU Munich, Munich, Germany.
Ernst WagnerDepartment of Pharmacy, Center of Drug Research, Pharmaceutical Biotechnology, LMU Munich, Munich, Germany.
Christine SpitzwegDepartment of Internal Medicine IV, University Hospital of Munich, LMU Munich, Munich, Germany. christine.spitzweg@med.uni-muenchen.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.